English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03646123 /

SGN35-027

Multiple Part Clinical Trial Of Brentuximab Vedotin In Classical Hodgkin Lymphoma Subjects

DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: